23 results on '"Zhang, Congli"'
Search Results
2. Dexmedetomidine mitigates acute kidney injury after coronary artery bypass grafting: a prospective clinical trial
- Author
-
Zhang, Congli, Zhang, Yang, Liu, Di, Mei, Mei, Song, Nannan, Zhuang, Qin, Jiang, Yiyao, Guo, Yuanyuan, Liu, Gang, Li, Xiaohong, and Ren, Li
- Published
- 2024
- Full Text
- View/download PDF
3. Study on strength and deformation characteristics of cemented gangue backfill body under the coupling action of load and salt erosion
- Author
-
Zhao, Yonghui, Guo, Yuxia, Feng, Guorui, Li, Chunqing, Xie, Wenshuo, and Zhang, Congli
- Published
- 2022
- Full Text
- View/download PDF
4. Targeted single‐cell RNA sequencing analysis reveals metabolic reprogramming and the ferroptosis‐resistant state in hematologic malignancies.
- Author
-
Shen, Xiaohui, Dong, Peiyuan, Kong, Jingjing, Sun, Nannan, Wang, Fang, Sang, Lina, Xu, Yan, Zhang, Mengmeng, Chen, Xiaoli, Guo, Rong, Wang, Shuya, Lin, Quande, Jiang, Zhongxing, Xu, Shan, Zhang, Congli, Bian, Zhilei, Wang, Weimin, and Guo, Rongqun
- Subjects
RNA sequencing ,HEMATOLOGIC malignancies ,ACUTE myeloid leukemia ,BONE marrow ,METABOLIC reprogramming - Abstract
Hematologic malignancies are the most common hematopoietic diseases and a major public health concern. However, the mechanisms underlying myeloid tumors remain unknown owing to the intricate interplay between mutations and diverse clonal evolution patterns, as evidenced by the analysis of bulk cell‐derived omics data. Several single‐cell omics techniques have been used to characterize the hierarchies and altered immune microenvironments of hematologic malignancies. The comprehensive single‐cell atlas of hematologic malignancies provides novel opportunities for personalized combinatorial targeted treatments, avoiding unwanted chemo‐toxicity. In the present study, we performed transcriptome sequencing by combining single‐cell RNA sequencing (scRNA‐seq) with a targeted oncogenic gene panel for acute myeloid leukemia, overcoming the limitations of scRNA‐seq in detecting oncogenic mutations. The distribution of oncogenic IDH1, IDH2, and KRAS mutations in each cell type was identified in the bone marrow (BM) samples of each patient. Our findings suggest that ferroptosis and metabolic reprogramming are involved in the tumorigenesis and chemotherapy resistance of oncogenic mutation‐carrying cells. Biological progression via IDH1, IDH2, and KRAS mutations arrests hematopoietic maturation. Our study findings provide a rationale for using primary BM cells for personalized treatment in clinical settings. Significance statement: The co‐occurrence of mutations in leukemia cells poses challenges in comprehending the occurrence and progression of leukemia, thereby impeding the adoption of personalized therapeutic approaches. By employing transcriptome sequencing that integrates single‐cell RNA sequencing with a targeted oncogenic gene panel, it becomes possible to identify oncogenic mutations at the individual cell level. This approach enhances our comprehension of disease heterogeneity, disease evolution, novel targeted treatment possibilities, and resistance to chemotherapy. Additionally, our investigation revealed a correlation between IDH1/2 and KRAS mutations and the processes of ferroptosis and metabolic reprogramming. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Recent progress on chemical vapor deposition growth of 2D materials.
- Author
-
Zhang, Congli
- Subjects
- *
CHEMICAL vapor deposition , *TRANSITION metal nitrides , *MOLECULAR dynamics , *BORON nitride , *CRYSTAL grain boundaries - Abstract
Remarkable progress has been made to understand the chemical vapor deposition (CVD) of two-dimensional (2D) materials over the last two decades. The review summarized the state-of-the-art experimental synthesis and modelling and simulation on 2D materials CVD growth. Firstly, the family of 2D materials, and their CVD growth processes are introduced. Secondly, the experimental synthesis and modelling and simulation on graphene growth are discussed. In particular, the applications of reactive molecular dynamics methods, kinetic Monte Carlo and density-functional theory in 2D material growth are addressed. Then, the CVD growth of hexagonal boron nitride and transition metal dichalcogenides are further discussed, focusing on the effects of reaction conditions (growth temperature, pressure, vapour-phase composition, etc.) on the domain morphologies, edge structures and grain boundaries of 2D materials. Last, conclusions and outlooks are presented. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Multi−Functional Gradient Fibrous Membranes Aiming at High Performance for Both Lithium–Sulfur and Zinc–Air Batteries.
- Author
-
Zhang, Congli, Geng, Zeyu, Meng, Ting, Ma, Fei, Xu, Xueya, Liu, Yang, and Zhang, Haifeng
- Subjects
LITHIUM sulfur batteries ,STORAGE batteries ,ENERGY storage ,FLEXIBLE electronics ,CHARGE exchange ,WEARABLE technology ,ZINC - Abstract
Lithium–sulfur batteries have been considered one of the most promising energy storage batteries in the future of flexible and wearable electronics. However, the shuttling of polysulfides, low sulfur utilization, and bad cycle stability restricted the widespread application of lithium–sulfur batteries. Currently, gradient materials with multiple functions can solve those defects simultaneously and can be applied to various parts of batteries. Herein, an electrospinningtriple−gradient Co−N−C/PVDF/PAN fibrous membrane was prepared and applied to lithium–sulfur batteries. The Co−N−C fibrous membrane provided efficient active sites, excellent electrode conductivity, and boosted polysulfide confinement. At the same time, the PVDF/PAN membrane enhances electron transfer and lithium−ion diffusion. As a result, the integrated S@Co−N−C/PVDF/PAN/Li battery delivered a high initial capacity of 1124.1 mA h g
−1 . Even under high sulfur loading (6 mg cm−2 ), this flexible Li–S battery still exhibits high areal capacity (846.9 mA h cm−2 ) without apparent capacity attenuation and security issues. Meanwhile, the gradient fibrous membranes can be used in zinc–air batteries, and the same double−gradient Co−N−C/PVDF membranes were also used as a binder−free air cathode with bifunctional catalytic activity and a facile hydrophobic and aerophile membrane, delivering remarkable cycling stability and small voltage gap in aqueous ZABs. The well−tunable structures and materials of the gradient strategy would bring inspiration for excellent performance in flexible and wearable energy storage devices. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
7. Fluvoxamine prompts the antitumor immune effect via inhibiting the PD‐L1 expression on mice‐burdened colon tumor.
- Author
-
Wei, Pengkun, Jia, Huijie, Li, Ruipeng, Zhang, Congli, Guo, Shuoshuo, Wei, Sujiao, Sun, Ke, Cheng, Sichang, Cui, Tongquan, Huang, Juan, Guo, Sheng, Guo, Jing, Yang, Zishan, Zhong, Jiateng, Lu, Chengbiao, Feng, Zhiwei, and Zhao, Tiesuo
- Subjects
COLON tumors ,PROGRAMMED cell death 1 receptors ,PROGRAMMED death-ligand 1 ,APOPTOSIS ,MATRIX metalloproteinases ,ALIMENTARY canal ,T cells - Abstract
A colon tumor, one of the digestive tract malignant tumors, is harmful to human health. A potential new treatment still deserves attention. The development of a new drug needs more resources, including time and expense. Therefore, the old drug with new targets has become a current research hotspot. Fluvoxamine, as an antidepressant, could play an effect on inhibiting 5‐hydroxytryptamine reuptake. In the present research, the antitumor effects and possible mechanisms of fluvoxamine are validated. The results showed that fluvoxamine significantly suppressed the migration and proliferation of tumor cells, and increased the apoptosis in vitro. Additionally, fluvoxamine significantly delays tumor development, and prompts the apoptosis in tumor tissues of mice‐burdened colon tumors in vivo. The tumor suppression might be related with that fluvoxamine inhibits the expression of phosphorylated signal transducer and activator of transcription 3, matrix metalloproteinase 2, and cleaved‐caspase 3. Importantly, fluvoxamine significantly reduces the expression level of programmed cell death ligand 1. This could be a possible reason that treatment with fluvoxamine drives the infiltration of T lymphocytes and M1‐type macrophages in tumor tissues. Taken together, this research suggests that fluvoxamine might be a promising drug to treat colon cancer by inhibiting the proliferation and migration, inducing apoptosis, and even increasing the immune response of antitumor. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. CLEC12A plays an important role in immunomodulatory function and prognostic significance of patients with acute myeloid leukemia.
- Author
-
Li, Qiaoqiao, Liang, Chunyan, Xu, Xintong, Zhang, Congli, Cao, Weijie, Wang, Meng, Jiang, Zhongxing, Xing, Haizhou, and Yu, Jifeng
- Subjects
ACUTE myeloid leukemia ,HEMATOPOIETIC stem cell transplantation ,REGULATORY T cells ,KILLER cells ,CHIMERIC antigen receptors - Abstract
The physiological function and prognostic significance of C-type lectin domain family 12 member A (CLEC12A) in acute myeloid leukemia (AML) patients are unclear. CLEC12A transcriptional expression in a variety of tumors from several public databases was collected and compared. We found that CLEC12A was highly expressed in AML cell lines and in tissues from AML patients and a higher CLEC12A expression in leukemia stem cells. CLEC12A low expression was associated with poor prognosis in the chemotherapy-only group and high CLEC12A expression may benefit from autologous or allogeneic hematopoietic stem cell transplantation (HSCT). CLEC12A expression was positively correlated with infiltrating levels of type 2 macrophages and monocytes and negatively associated with NK cells and regulatory T cells in AML. CLEC12A high was positively associated with immune checkpoint genes as well as macrophage associated genes. CLEC12A is an ideal chimeric antigen receptor T-cell (CAR-T) therapy target for AML and its expression level was closely linked to treatment response and patients' survival outcome. CLEC12A plays an important immunomodulatory role in AML. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. Effects of regulating miR-132 mediated GSK-3β on learning and memory function in mice.
- Author
-
Liu, Gang, Yin, Fengwei, Zhang, Congli, Zhang, Yang, Li, Xiaohong, and Ling, Yunzhi
- Subjects
WESTERN immunoblotting ,MEMORY disorders ,LEARNING disabilities ,MICE ,INTELLIGENCE tests ,MAZE tests - Abstract
The aimf of this study was to explore effects of miR-132 and glycogen synthase kinase-3β (GSK-3β) on learning and memory in mice. miR-132 inhibitor GSK-3β overexpression agent (sh-GSK-3β) and normal saline (negative control group) were injected into the hippocampus of adult mice, and healthy adult mice were taken as the unrelated control group. The expression of miR-132 and GSK-3β in the hippocampus of adult and elderly mice was detected using reverse transcription-quantitative PCR (RT-qPCR) and western blot analysis. Morris water maze test was employed to detect learning and memory function in mice. The dual luciferase reporter was adopted to determine the relationship between miR-132 and GSK-3β. Compared with the adult group, the expression of miR-132 was significantly downregulated in the hippocampus in the elderly group, while the expression of GSK-3β was upregulated. Injecting miR-132 inhibitor into the hippocampus of adult mice led to a significant increase in escape latency and a significant decrease in the number of times of crossing platforms. The injection of GSK-3β overexpression agent into the hippocampus of adult mice resulted in a marked increase in escape latency and a significant decrease in the number of times of crossing platforms in the water maze test. It was also found that downregulation of GSK-3β reversed the decline in learning and memory in mice caused by downregulation of miR-132 expression. The dual luciferase report identified a targeted regulatory relationship between miR-132 and GSK-3β. Overexpression of miR-132 can inhibit the expression of GSK-3β in mouse learning and memory ability, which provides some inspiration for understanding the occurrence of learning and memory disorders and future treatment methods. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
10. Bortezomib-Based Chemotherapy Reduces Early Mortality and Improves Outcomes in Patients with Ultra-High-Risk Light-Chain Amyloidosis
- Author
-
Shen, Kaini, Zhang, Congli, Feng, Jun, Zhang, Lu, Cao, Xinxin, Zhou, Daobin, and Li, Jian
- Published
- 2018
- Full Text
- View/download PDF
11. A novel method of automatic peeling for Poria cocos based on image processing.
- Author
-
Zhang, Xiongchu, Chen, Bingqi, Zheng, Zhian, Wang, Wenjie, Fang, Xin, and Zhang, Congli
- Subjects
- *
LIGHT sources , *MILLING-machines , *EPIDERMIS , *PROBLEM solving , *PIXELS , *ACHROMATISM - Abstract
Manual peeling of Poria cocos has low efficiency and large loss, and other peeling methods are not suitable for Poria cocos peeling. To solve this problem, this study designed and fabricated a set of automatic peeling equipment for Poria cocos, which combined image processing technology with the structure and function of the vertical milling machine. This paper mainly reports the image detection algorithm of Poria cocos epidermis position for automatic peeling. Firstly, the blue marks were glued to the movable and the immovable parts of clamping parts, and the initial window was determined through them. Then, the grayscale image within the initial window was obtained with the help of the chromatic aberration |2r-g-b| (red (r), green (g), blue (b) of pixels). The processing window was calculated with the aid of the distribution graph of the grayscale accumulation. Next, the grayscale image was taken into the process of the automatic binarization based on the Otsu method and the binary image was restored through dilation, erosion and denoising algorithm. Finally, pixel columns in the processing window were scanned column-by-column from the left to the right and the direction of each pixel column is from the bottom to the top. The first pixel with a value of 0 on each pixel column was set as the epidermis position of the current pixel column. The experiment results implied that, under the set light source, the average detection accuracy was 98.8%, and the average time to detect epidermis position once was 0.024 s. The detection accuracy and real-time performance of this algorithm meets the actual operation requirements of Poria cocos peeling. It lays the foundation for the automatic peeling operation of Poria cocos. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. Comparison of clinical outcomes and perinatal outcomes between natural cycle and hormone replacement therapy of frozen-thawed embryo transfer in patients with regular menstruation: a propensity score-matched analysis.
- Author
-
Sun L, Yin B, Yao Z, Zhang C, Li J, Li S, Cui Y, Wang F, Dai W, Bu Z, and Zhang Y
- Subjects
- Humans, Female, Pregnancy, Adult, Retrospective Studies, Pregnancy Rate, Menstruation, Live Birth epidemiology, Fertilization in Vitro methods, Menstrual Cycle physiology, Embryo Transfer methods, Hormone Replacement Therapy methods, Propensity Score, Pregnancy Outcome epidemiology, Cryopreservation
- Abstract
Purpose: To investigate potential differences in pregnancy outcomes among patients with regular menstruation who underwent frozen-thawed embryo transfer using natural cycle (NC) or hormone replacement therapy (HRT)., Methods: This study retrospectively analyzed 2672 patients with regular menstruation who underwent FET from November 2015 to June 2021 at the single reproductive medical center. A one-to-one match was performed applying a 0.02 caliper with propensity score matching. Independent factors influencing the live birth and clinical pregnancy rates were screened and developed in the nomogram by logistic regression analysis. The efficacy of live birth rate and clinical pregnancy rate prediction models was assessed with the area under the ROC curve, and the live birth rate prediction model was internally validated within the bootstrap method., Results: The NC protocol outperformed the HRT protocol in terms of clinical pregnancy and live birth rates. The stratified analysis revealed consistently higher live birth and clinical pregnancy rates with the NC protocol across different variable strata compared to the HRT protocol. However, compared to the HRT treatment, perinatal outcomes indicated that the NC protocol was related to a higher probability of gestational diabetes. Multifactorial logistic regression analysis demonstrated independent risk factors for live birth rate and clinical pregnancy rate. To predict the two rates, nomogram prediction models were constructed based on these influencing factors. The receiver operating characteristic curve demonstrated moderate predictive ability with an area under curve (AUC) of 0.646 and 0.656 respectively. The internal validation of the model for live birth rate yielded an average AUC of 0.646 implying the stability of the nomogram model., Conclusion: This study highlighted that NC yielded higher live birth and clinical pregnancy rates in comparison to HRT in women with regular menstruation who achieved successful pregnancies through frozen-thawed embryo transfer. However, it might incur a higher risk of developing gestational diabetes., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Sun, Yin, Yao, Zhang, Li, Li, Cui, Wang, Dai, Bu and Zhang.)
- Published
- 2024
- Full Text
- View/download PDF
13. Nifuroxazide suppresses PD-L1 expression and enhances the efficacy of radiotherapy in hepatocellular carcinoma.
- Author
-
Zhao T, Wei P, Zhang C, Zhou S, Liang L, Guo S, Yin Z, Cheng S, Gan Z, Xia Y, Zhang Y, Guo S, Zhong J, Yang Z, Tu F, Wang Q, Bai J, Ren F, Feng Z, and Jia H
- Subjects
- Animals, Mice, B7-H1 Antigen, Hydroxybenzoates, Carcinoma, Hepatocellular drug therapy, Carcinoma, Hepatocellular radiotherapy, Liver Neoplasms drug therapy, Liver Neoplasms radiotherapy, Nitrofurans
- Abstract
Radiation therapy is a primary treatment for hepatocellular carcinoma (HCC), but its effectiveness can be diminished by various factors. The over-expression of PD-L1 has been identified as a critical reason for radiotherapy resistance. Previous studies have demonstrated that nifuroxazide exerts antitumor activity by damaging the Stat3 pathway, but its efficacy against PD-L1 has remained unclear. In this study, we investigated whether nifuroxazide could enhance the efficacy of radiotherapy in HCC by reducing PD-L1 expression. Our results showed that nifuroxazide significantly increased the sensitivity of tumor cells to radiation therapy by inhibiting cell proliferation and migration while increasing apoptosis in vitro. Additionally, nifuroxazide attenuated the up-regulation of PD-L1 expression induced by irradiation, which may be associated with increased degradation of PD-L1 through the ubiquitination-proteasome pathway. Furthermore, nifuroxazide greatly enhanced the efficacy of radiation therapy in H22-bearing mice by inhibiting tumor growth, improving survival, boosting the activation of T lymphocytes, and decelerating the ratios of Treg cells in spleens. Importantly, nifuroxazide limited the increased expression of PD-L1 in tumor tissues induced by radiation therapy. This study confirms, for the first time, that nifuroxazide can augment PD-L1 degradation to improve the efficacy of radiation therapy in HCC-bearing mice., Competing Interests: TZ, PW, CZ, SZ, LL, SG, ZY, SC, ZG, YX, YZ, SG, JZ, ZY, FT, QW, JB, FR, ZF, HJ No competing interests declared, (© 2023, Zhao, Wei et al.)
- Published
- 2024
- Full Text
- View/download PDF
14. Impact factors of benefiting from initial 131 I ablation in patients with intermediate-risk differentiated thyroid carcinoma: a study based on a re-evaluation of therapeutic response.
- Author
-
Ren L, Hu Y, Hu Y, Xiao D, Sun J, Zhu B, and Zhang C
- Subjects
- Humans, Female, Thyroglobulin, Retrospective Studies, Thyroidectomy, Iodine Radioisotopes therapeutic use, Treatment Outcome, Thyroid Neoplasms surgery, Adenocarcinoma
- Abstract
Objective: This study was carried out to confirm whether patients with intermediate-risk differentiated thyroid cancer (DTC) could benefit from initial 131 I ablation and to identify the factors that impacted the benefit., Methods: We retrospectively assessed a cohort of 548 patients with intermediate-risk DTC who were classified into structural incomplete response (SIR), biochemical incomplete response (BIR), indeterminate response (IDR), and excellent response (ER) groups according to the ATA guidelines (version 2015). A downgrade in the classification, such as from initial SIR to final BIR, IDR, or ER, from BIR to IDR or ER, and from initial IDR to final ER, was defined as benefiting from initial 131 I ablation (benefit group). Non-downgraded classification meant non-benefit., Results: 64.78% of patients benefited from the initial 131 I ablation in the final re-evaluation. Gender (OR = 0.038, P = 0.002), interval time (OR = 0.038, P = 0.002) and serum ps-Tg (OR = 0.961, P = 0.001) were independent prognostic factors for benefiting from initial 131 I ablation, with the cutoff value were 5 months and 19.08 ng/ml., Conclusion: Patients with intermediate-risk DTC could benefit from initial 131 I ablation. Female patients with intermediate-risk DTC whose interval time <5 months and ps-Tg <19.08 ng/ml were more likely to benefit. Early 131 I ablation for such patients is beneficial for achieving a complete therapeutic response., (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
15. Prognostic value of circulating plasma cells detected by flow cytometry in newly diagnosed multiple myeloma patients: a systematic review and meta-analysis.
- Author
-
Liu X, Wu F, Ye W, Deng J, Zhang M, Zhang C, Yu Q, Cao L, Gan S, and Ma J
- Subjects
- Humans, Prognosis, Plasma Cells pathology, Flow Cytometry, Reproducibility of Results, Transplantation, Autologous, Multiple Myeloma diagnosis, Multiple Myeloma therapy, Hematopoietic Stem Cell Transplantation methods
- Abstract
Objectives: Multiple myeloma (MM) is a malignant plasma cell disorder. The most widely accepted staging system for MM is the revised International Staging System based on cytogenetic and clinical biomarkers. The circulating clonal plasma cells (CPCs) were reported to have potential prognostic impact on MM. Among various diagnostic approaches, multiparametric flow cytometry (FCM) offers heightened sensitivity, minimal invasiveness and reproducibility. We conducted a meta-analysis to evaluate the prognostic value of quantifying CPCs via FCM in newly diagnosed symptomatic MM (NDMM) patients., Design: Systematic review and meta-analysis., Data Source: PubMed, Web of Science, Embase and references of included studies., Eligibility Criteria for Selecting Studies: We included observational studies that evaluated the prognostic value of CPCs detected by FCM in NDMM., Data Extraction and Synthesis: Data were screened and extracted independently by two investigators. The pooled results originated from random effects models. The primary endpoint was overall survival (OS). The secondary endpoint was progression-free survival (PFS). To evaluate the prognostic value of CPCs in NDMM, HRs and their 95% CI for both OS and PFS were derived using COX multivariable models. These values were then used to compute the pooled estimated effect., Results: Our meta-analysis encompassed a total of 2704 NDMM patients from 11 studies up to 27 August 2022. The pooled HR for OS and PFS in CPC-positive (CPCs+) group and CPC-negative group were 1.95 (95% CI 1.24 to 3.07) and 2.07 (95% CI 1.79 to 2.39), respectively. The autologous stem cell transplantation (ASCT) failed to eliminate the adverse impact on OS and PFS. The heterogeneity may stem from the use of novel agents or traditional chemotherapy as initial treatment., Conclusion: This meta-analysis indicates CPCs+ had an adverse impact on the prognosis of NDMM patients in the total population, and the adverse impact could not be eliminated by ASCT., Prospero Registration Number: CRD42021272381., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
16. Comparing Day 5 versus Day 6 euploid blastocyst in frozen embryo transfer and developing a predictive model for optimizing outcomes: a retrospective cohort study.
- Author
-
Yin B, Li S, Sun L, Yao Z, Cui Y, Zhang C, and Zhang Y
- Subjects
- Pregnancy, Female, Humans, Pregnancy Rate, Retrospective Studies, Blastocyst, Embryo Implantation, Embryo Transfer methods
- Abstract
Background: Optimal protocols for frozen-thawed embryo transfer (FET) after preimplantation genetic testing (PGT) remain unclear. This study compared Day 5 (D5) and Day 6 (D6) blastocysts and evaluated predictors of FET success., Methods: A total of 870 patients with genetic diseases or chromosomal translocations who received PGT at the First Affiliated Hospital of Zhengzhou University from January 2015 to December 2019 were recruited. All patients underwent at least one year of follow-up. Patients were divided into groups according to the blastocyst development days and quality. Univariate and multivariate logistic regression were applied to identify risk factors that affect clinical outcomes and to construct a predictive nomogram model. Area under the curve (AUC) of the subject's operating characteristic curve and GiViTI calibration belt were conducted to determine the discrimination and fit of the model., Results: D5 blastocysts, especially high-quality D5, resulted in significantly higher clinical pregnancy (58.4% vs 49.2%) and live birth rates (52.5% vs 45%) compared to D6. Multivariate regression demonstrated the number of blastocysts, endometrial preparation protocol, days of embryonic development and the quality of blastocysts independently affected live birth rates ( P<0.05 ). A nomogram integrating these factors indicated favorable predictive accuracy (AUC=0.598) and fit (GiViTI, P=0.192 )., Conclusions: Transferring high-quality D5 euploid blastocysts after PGT maximizes pregnancy outcomes. Blastocyst quality, blastocyst development days, endometrial preparation protocols, and number of blastocysts, independently predicted outcomes. An individualized predictive model integrating these factors displayed favorable accuracy for counseling patients and optimizing clinical management., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Yin, Li, Sun, Yao, Cui, Zhang and Zhang.)
- Published
- 2024
- Full Text
- View/download PDF
17. Dexmedetomidine Attenuates Total Body Radiation-Induced Acute Liver Injury in Mice Through the Nrf2/HO-1 Pathway.
- Author
-
Zhang C, Ren L, Zou M, Xu W, Zhang W, Liu G, Zhu B, Xu H, Meng X, Li X, and Ji F
- Subjects
- Animals, Liver metabolism, Mice, Oxidative Stress, Reactive Oxygen Species metabolism, Superoxide Dismutase, Tumor Necrosis Factor-alpha, Dexmedetomidine metabolism, Dexmedetomidine pharmacology, Dexmedetomidine therapeutic use, NF-E2-Related Factor 2 metabolism, NF-E2-Related Factor 2 pharmacology
- Abstract
Background: The purpose of this study was to investigate the protective effects of dexmedetomidine (DEX) on total body radiation-induced acute liver injury in mice and to explore the possible mechanisms., Methods: A total of 40 mice were randomly divided into the Control group (Group C), Dexmedetomidine group (Group Dex), Radiation group (Group R), and Group R+Dex. Mice in Group Dex and Group R+Dex were intraperitoneally injected with 10 µg/mL Dex at 50 mg/kg. Both Group C and Group R received normal saline instead of Dex. Mice were treated via continuous administration for 10 days and injection once a day (pre-administration for 3 days and 7 days after radiation). One hour after administration on the third day, the mice in Group R and R+Dex received total body radiation with a total dose of 6 Gy at a rate of 2 Gy/min. Group C received sham radiation. Levels of aspartate aminotransferase (AST), serum alanine aminotransferase (ALT), and liver levels of tumor necrosis factor (TNF-α), interleukin-1β (IL-1β), reactive oxygen species (ROS), superoxide dismutase (SOD), malondialdehyde (MDA) were measured. HE staining was employed to evaluate the pathological changes in liver tissues, and the expressions of Nrf2 and HO-1 proteins in the liver were measured by western blot., Results: Compared with group C, serum levels of AST and ALT, liver TNF-α, IL-1β, MDA, and ROS levels increased, and SOD decreased in Group R. Group R mice had higher liver injury scores, and the protein expressions of Nrf2 and HO-1 proteins were lower (p < 0.05). Compared with Group R, the levels of AST, ALT, TNF-α, IL-1β, MDA, and ROS decreased, SOD increased, liver injury scores were lower, and the expressions of Nrf2 and HO-1 proteins were higher in the Group R+Dex group (all p < 0.05)., Conclusions: Dex exhibits a protective effect on reducing acute radiation-induced liver injury and oxidative stress, and the mechanism may be associated with the activation of Nrf2/HO-1 pathways.
- Published
- 2022
- Full Text
- View/download PDF
18. The Value of Stimulated Thyroglobulin Before the First Radioactive Iodine Treatment in Metastasis for Differentiated Thyroid Carcinoma.
- Author
-
Ren L, Zhang C, Shen Y, Mo A, Hu Y, Sun J, Yuan C, and Wen W
- Subjects
- Humans, Iodine Radioisotopes therapeutic use, Retrospective Studies, Thyroglobulin, Thyroidectomy, Iodine, Thyroid Neoplasms diagnostic imaging, Thyroid Neoplasms radiotherapy, Thyroid Neoplasms surgery
- Abstract
Background: To evaluate the value of preablative stimulated thyroglobulin (ps-Tg) before the first radioactive ablation iodine (RAI) treatment to predict the postoperative metastasis of DTC., Methods: A total of 235 DTC patients, who underwent total thyroidectomy and neck lymph node dissection, were enrolled. On the basis of the presence or absence of metastasis, all patients were divided into metastasis (M1) and non-metastasis (M0) groups. Besides, the patients in the M1 group were further divided into two subgroups according to sites of metastasis. These groups included cervical lymph node metastasis and distant metastasis groups. Subsequently, the level of serum ps-Tg was measured 3 - 4 days before the first RAI ablation treatment, whereas 131I whole-body imaging and SPECT/CT tomography were performed 5 - 7 days after radio ablation. Subsequently, the Mann Whitney U test was used to compare the different levels of ps-Tg between the two groups. Additionally, the relationship between ps-Tg and the metastasis of DTC was analyzed through correlation analysis, regression analysis, and the ROC curve., Results: The ps-Tg level in the M1 group was higher than that in the M0 group. Further analysis discovered that the ps-Tg in the distant metastasis group was higher than that in the cervical lymph node metastasis and non-metastasis groups. Also, the ps-Tg level was positively correlated with distant metastasis (r = 0.599, p = 0.000). Besides, the results of multivariate logistic regression analysis outlined that the level of ps-Tg was an independent risk factor for the development of distant metastasis (OR = 1.008, p = 0.018). Subsequently, the results from the ROC analysis also showed a good diagnostic performance for ps-Tg in treating distant metastasis (AUC = 0.964, p = 0.000), and the optimal cutoff value was 61.87 ng/mL., Conclusions: The ps-Tg in patients with DTC before the first RAI ablation treatment is an independent risk factor and a meaningful indicator in predicting postoperative distant metastasis.
- Published
- 2021
- Full Text
- View/download PDF
19. Research on the Application Value of Serum and Urine β2-Microglobulin in Immunoglobulin a Nephropathy.
- Author
-
Ren L, Zhang C, Wen W, Pan Y, Chen H, Sun W, and Sun J
- Subjects
- Adult, Biomarkers, China, Female, Glomerular Filtration Rate, Humans, Kidney, Male, Middle Aged, Glomerulonephritis, IGA diagnosis
- Abstract
Background: To compare the application value of serum and urinary β2-microglobulin in immunoglobulin A nephropathy (IgAN)., Methods: Two hundred thirteen patients were hospitalized at the First Affiliated Hospital of Bengbu Medical College in China because of physical abnormalities and diagnosed with IgAN by means of renal biopsy between January 2010 and December 2018. β2-MG levels in serum and urine were detected through immunoturbidimetric methods. The renal histopathology was quantified according to Katafuchi semi-quantitative standards and Lee's grading., Results: One hundred twenty-four patients were male and 89 cases were female, for a 1.39:1 male to female ratio. The average age was 38.25 ± 12.48 years old when patients received their first renal biopsy. The levels of serum β2-MG and urine β2-MG increased gradually with the aggravation of tubulointerstitial lesions. Results of correlation analysis showed that serum β2-MG had higher application value. Serum β2-MG levels were positively correlated with SCr and tubulointerstitial lesions (r = 0.840, 0.652, p = 0.000), negatively correlated with CG-eGFR (r = -0.680, p = 0.000). The results of multivariate logistic regression analysis showed that serum β2-MG was a marker of independent risk factor for the score of tubulointerstitial lesions ≥ 3 (OR = 6.649, p = 0.000). ROC analysis showed better diagnostic performance for serum β2-MG, with the optimal cutoffs in predicting tubulointerstitial score ≥ 1, score ≥ 4 and score ≥ 7 of 1.905 mg/L, 2.13 mg/L, and 4.49 mg/L, respectively., Conclusions: Serum β2-MG is valuable in evaluating renal function and pathological lesions in IgAN patients and has significant predictive value in evaluating tubulointerstitial lesions. Serum β2-MG may be used as a non-invasive diagnostic indicator for predicting renal function and tubulointerstitial lesions in IgAN.
- Published
- 2020
- Full Text
- View/download PDF
20. Left and right ventricular myocardial deformation and late gadolinium enhancement: incremental prognostic value in amyloid light-chain amyloidosis.
- Author
-
Li X, Li J, Lin L, Shen K, Tian Z, Sun J, Zhang C, An J, Jin Z, Vliegenthart R, Selvanayagam JB, and Wang Y
- Abstract
Background: Previous cardiac magnetic resonance (CMR) studies have shown that both late gadolinium enhancement (LGE) and left ventricular (LV) strain have prognostic value in amyloid light-chain (AL) amyloidosis, but the right ventricular (RV) strain has not yet been studied. We aim to determine the incremental prognostic value of LV and RV LGE and strain in AL amyloidosis., Methods: This prospective study recruited 87 patients (age, 56.9±9.1 years; M/F, 56/31) and 20 healthy subjects (age, 52.7±8.1 years; M/F, 11/9) who underwent CMR. The LV LGE was classified into no, patchy and global groups. The RV LGE was classified into negative and positive groups. Myocardial deformation was measured using a dedicated software. Follow-up was performed for all-cause mortality using Cox proportional hazards regression and Kaplan-Meier curves., Results: During a median follow-up of 21 months, 34 deaths occurred. Presence of LV LGE [HR 2.44, 95% confidence interval (CI), 1.10-5.45, P=0.029] and global longitudinal strain (GLS) (HR 1.13 per 1% absolute decrease, 95% CI, 1.02-1.25, P=0.025) were independent LV predictors. RV LGE (HR 4.07, 95% CI, 1.09-15.24, P=0.037) and GLS (HR 1.10 per 1% absolute decrease, 95% CI, 1.00-1.21, P=0.047) were independent RV predictors. Complementary to LV LGE, LV GLS impairment or RV LGE further reduced survival (both log rank P<0.001)., Conclusions: This study confirms the incremental prognostic value of LV GLS and RV LGE in AL amyloidosis, which refines the conventional risk evaluation based on LV LGE. GLS based on non-contrast-enhanced CMR are promising new predictors., Competing Interests: Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/cdt-20-181). JBS serves as an unpaid editorial board member of Cardiovascular Diagnosis and Therapy from Jul 2019 to Jun 2021. The authors have no other conflicts of interest to declare., (2020 Cardiovascular Diagnosis and Therapy. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
21. The Value of Serum IgA in the Diagnosis, Clinical and Pathological Evaluation of Patients with IgA Nephropathy Found During Physical Examination in China.
- Author
-
Ren L, Zhang C, Pan Y, and Sun J
- Subjects
- Adult, Asian People, Biopsy, China, Creatinine blood, Female, Glomerulonephritis, IGA ethnology, Glomerulonephritis, IGA pathology, Humans, Kidney immunology, Kidney pathology, Male, Middle Aged, ROC Curve, Retrospective Studies, Glomerulonephritis, IGA diagnosis, Immunoglobulin A blood, Incidental Findings, Physical Examination methods
- Abstract
Background: The goal was to study the role of serum IgA in patients with IgA nephropathy (IgAN) found during physical examination, and to explore its value in diagnosis, assessment of pathological injury, and clinical prediction of IgAN., Methods: The study included 457 patients who were hospitalized between January 2010 and June 2018 due to physical abnormalities and diagnosed with kidney disease via renal biopsy. Renal histopathology was quantified according to Katafuchi semi-quantitative standards, while the IgAN patients were also scored according to Lee's grading system., Results: The average age of the 457 patients was 39.62 ± 13.52 years when abnormalities were found during physical examination. IgAN (202 cases, 46.12%) was the most common type of primary glomerulonephritis in the 457 patients. Of the IgAN patients, 75.25% (152 cases) were under 45 years old at the time of abnormal physical examination and IgAN patients were significantly younger than non-IgAN patients. There was a significant difference in the gender ratio between IgAN patients and non-IgAN patients (χ2 = 4.24, p = 0.039). In IgAN patients, the proportion of male patients, serum creatinine (SCr), the glomerular lesion and tubulointerstitial scores, and serum IgA were statistically higher than in non-IgAN patients with other types of primary glomerulonephritis; however, MDRD-GFR was lower. The ROC curve of serum IgA in the diagnosis of IgAN showed the AUC was 0.602. One hundred forty-seven cases (72.77%) were Lee's III - V grade. The proportion of patients who were at Lee's III - V grades in the normal serum IgA group (184 cases) was higher than that of the elevated serum IgA group (18 cases). There were no significant differences in gross hematuria, proteinuria, MDRD-GFR, SCr, and hypertension between the two groups., Conclusions: Serum IgA may be of little value in the diagnosis of patients with IgA nephropathy detected via physical examination. The level of serum IgA may have predictive value in evaluating Lee's pathological damage in IgAN patients.
- Published
- 2019
- Full Text
- View/download PDF
22. Outcome of Cardiac Light-Chain Amyloidosis in the Era of Novel Therapy - A Single-Center Cohort Study of 227 Patients.
- Author
-
Feng J, Zhang C, Shen K, Sun J, Fang Q, Zhang L, Cao X, Zhou D, Li J, and Tian Z
- Subjects
- Adult, Aged, Antineoplastic Agents therapeutic use, Blood Pressure, Bone Marrow Cells cytology, Bortezomib therapeutic use, Cohort Studies, Female, Heart Diseases therapy, Hematopoietic Stem Cell Transplantation methods, Humans, Immunoglobulin Light-chain Amyloidosis mortality, Male, Middle Aged, Natriuretic Peptide, Brain blood, Palliative Care, Prognosis, Survival Analysis, Transplantation, Autologous, Treatment Outcome, Heart Diseases etiology, Immunoglobulin Light-chain Amyloidosis complications, Immunoglobulin Light-chain Amyloidosis therapy
- Abstract
Background: Cardiac involvement occurs in more than half of the patients with light-chain amyloidosis (AL), but the characteristics, treatment and prognosis of cardiac AL (CAL) are not fully described. Methods and Results: A total of 227 patients with CAL diagnosis between January 2009 and March 2017 at Peking Union Medical College Hospital were included. Patients with Mayo stages I, II and III AL accounted for 0.9%, 49.8% and 49.3%, respectively. Autologous stem cell transplantation, bortezomib combinations, non-bortezomib regimens and palliative treatment were given as first line therapy in 3.1%, 44.1%, 30.8% and 22.0% of patients, respectively. Overall hematological response and cardiac response were achieved in 60.6% and 37.2% of evaluable patients, respectively. The median overall survival (OS) was 17 months in all patients, and 10 months in those with Mayo stage III. In patients with Mayo stage III disease who survived for >1 month, the bortezomib group survived significantly longer than the non-bortezomib group (median OS, not reached vs. 12 months, P=0.019). Three independent prognostic factors for survival were identified: N-terminal fragment of B-type natriuretic peptide (NT-proBNP) ≥5,000 pg/mL, bone marrow plasma cells ≥10%, and systolic blood pressure <100 mmHg., Conclusions: CAL patients had poor prognosis, but those treated with bortezomib combinations had a better outcome than the non-bortezomib group.
- Published
- 2019
- Full Text
- View/download PDF
23. [The usage of Mayo staging system in Chinese patients with primary light chain amyloidosis].
- Author
-
Huang X, Feng J, Zhang C, Shen K, Zhang C, Sun J, Tian Z, Cao X, Zhang L, Zhou D, and Li J
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Immunoglobulin Light-chain Amyloidosis, Male, Middle Aged, Prognosis, Retrospective Studies, Young Adult, Amyloidosis diagnosis
- Abstract
Objective: To evaluate the usage of Mayo staging system in Chinese patients with primary light chain (LC) amyloidosis., Method: Clinical data, treatment and outcome of 162 primary LC amyloidosis patients with Mayo Clinic staging in Peking Union Medical College Hospital from January 2009 to June 2015 were retrospectively analyzed., Results: The median age of 162 patients with Mayo Clinic 2004 stage was 57 (20-81) y, of them 62.3% were male. The number of patients with stage I to III were 44 (27.2%), 69 (42.6%), and 49 (30.2%), respectively. The median overall survival was not reached, 23 months and 12 months in patients with Mayo Clinic 2004 stage I, II, and III, respectively (P<0.001). Among 128 patients with Mayo Clinic 2012 stage, 48 patients (37.5%), 32 patients (25.0%), 32 patients (25.0%) and 16 patients (12.5%) were staged as Mayo Clinic 2012 stage 1 to 4, and the median OS was not reached, not reached, 13 months and 3 months, respectively (P<0.001)., Conclusion: Mayo Clinic staging systems had important prognostic value in patients with primary LC amyloidosis.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.